IBRO Neuroscience Reports · 2024 · 34 citations · 52 references
MedicinePharmacologyPsychiatryNeurochemistryNeuropharmacologyPsychopharmacologyAntipsychotic PharmacologyAntipsychotic PharmacotherapyAntipsychotic TherapyNeurochemical PharmacologyNeuroprotectionSchizophrenia PharmacotherapyAntioxidant PropertiesAntipsychotic ActionAntipsychotic EfficacyKetamine TreatmentMurine ModelsOxidative Stress InjuryRisperidone TherapySchizophrenia Models
./day) treatment from days 8-14. Mice were assessed for behavioral changes. Oxidative, nitrergic markers, and cholinergic (acetylcholinesterase activity) transmission were examined in the striatum, prefrontal-cortex and hippocampus. Diosgenin prevented and reversed hyperlocomotion, cognitive and social deficits in mice treated with ketamine relative to ketamine groups. The increased acetylcholinesterase, malondialdehyde and nitrite levels produced by ketamine were reduced by diosgenin in the striatum, prefrontal-cortex and hippocampus, but did not reverse striatal nitrite level. Diosgenin increased glutathione, and catalase levels, except for hippocampal catalase activity when compared with ketamine controls. Conclusively, these biochemical changes might be related to the behavioral deficits in ketamine-treated mice, which were prevented and reversed by diosgenin.
52
Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids
Laura C. Green, David A. Wagner, Joseph A. Glogowski et al. · Analytical Biochemistry · 1982 · 12.1K citations